Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial

著者: Giovanni Grignani, Emanuela Palmerini, Virginia Ferraresi, Lorenzo D’Ambrosio, Rossella Bertulli, Sebastian Dorin Asaftei, Angela Tamburini, Ymera Pignochino, Dario Sangiolo, Emanuela Marchesi, Federica Capozzi, R. Biagini, Marco Gambarotti, Franca Fagioli, Paolo G. Casali, Piero Picci, Stefano Ferrari, Massimo Aglietta - The Lancet 2014 被引用: 335